Latest Insights on MRNA
An Investor’s Guide to Moderna Stock
January 18, 2023 Investing
COVID-19 introduced a race for a vaccine, but how does Moderna stock (Nasdaq: MRNA) rate now that the pandemic is in the rearview mirror? “Bullish” Moderna’s Latest Moves: Stock Power Breakdown
October 28, 2022 Investing
Things aren't quite back to normal yet, but it looks a lot less bleak because of the vaccines. Especially for Moderna's stock. A 1,700% Shot in the Arm: MRNA Put the Spotlight on Genomics
May 26, 2022 Investing
Mega trends are imperative while in a bear market. Moderna helped genomics shoot to the top, see how this can help spot future trends. 3 Market Mega Trends for 2022 and Beyond
December 10, 2021 Investing
There are plenty of market mega trends to track in 2022. Here are three that chief investment strategist Adam O'Dell is most excited about. COVID Trade Is Dead: Genomics Is Ready for the Spotlight
November 12, 2021 Investing
COVID-19 may not be a reliable investing theme anymore, but it opened the door for the biggest stock mega trend of the next decade.